RHUMBLINE ADVISERS - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$239,622
-41.4%
141,795
-3.6%
0.00%
Q2 2023$409,063
+201408.9%
147,145
+31.6%
0.00%
Q1 2023$203
-64.4%
111,774
-0.7%
0.00%
-100.0%
Q4 2022$571
-99.9%
112,604
+2.8%
0.00%0.0%
Q3 2022$544,000
+44.7%
109,527
+8.4%
0.00%0.0%
Q2 2022$376,000
-23.9%
101,032
+14.6%
0.00%0.0%
Q1 2022$494,000
-10.0%
88,123
-2.4%
0.00%0.0%
Q4 2021$549,000
-39.0%
90,278
-2.3%
0.00%0.0%
Q3 2021$900,000
-29.3%
92,408
+3.7%
0.00%
-50.0%
Q2 2021$1,273,000
+41.4%
89,140
+135.3%
0.00%
+100.0%
Q1 2021$900,00037,8910.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders